NDC 65219-826 – Otulfi

Ustekinumab 90 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC65219-826

Product details

Brand name
Otulfi
Generic name
Ustekinumab-aauz
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761379
Marketed since
February 22, 2024
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Otulfi →

Package NDC codes (1)

Package NDCDescriptionSince
65219-826-261 SYRINGE in 1 CARTON (65219-826-26) / 1 mL in 1 SYRINGEFeb 22, 2024

Other Otulfi products